Cost-Utility Analysis of Heberprot-P as an Add-on Therapy to Good Wound Care for Patients in Slovakia with Advanced Diabetic Foot Ulcer

Objectives: To explore whether Heberprot-P (an epidermal growth factor) is a cost-effective option for the treatment of advanced diabetic foot ulcer as an add-on therapy to good wound care (GWC) in Slovakia from the perspective of health care payers. Methods: A Markov model was constructed to compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Tesar, Tomas, Szilberhorn, Laszlo, Nemeth, Bertalan, Nagy, Balazs, Wawruch, Martin, Kalo, Zoltan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743698/
https://www.ncbi.nlm.nih.gov/pubmed/29311943
http://dx.doi.org/10.3389/fphar.2017.00946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743698/
https://www.ncbi.nlm.nih.gov/pubmed/29311943
http://dx.doi.org/10.3389/fphar.2017.00946

Ejemplares similares